Health Management

July 23, 2020

Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.

July 22, 2020

MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.

July 11, 2020

Jim Beiermann, CFO, and Danny Irland, senior vice president of network operations and chief network officer of Southwestern Health Resources discuss their focus of value-based care through ACO and Next Generation Programs within the company with Managed Healthcare Executive Senior Editor, Peter Wehrwein.

July 10, 2020

The healthcare tech company will assist health plans in meeting Care for Older Adults requirements.

July 10, 2020

Jim Beiermann and Danny Irland, both of Southwestern Health Resources, discuss their focus of value-based care through ACO and Next Generation Programs.

July 02, 2020

Of the 87% of executives who see convergence already happening, 89% say it is accelerating—up from 21% who said the same in 2018.

June 23, 2020

Early studies from China suggested that CT scans of the lungs could be used to diagnose the disease. But as PCR tests became available, radiology groups said CT scans should be used more sparingly and in confirmed cases.

June 22, 2020

During the American Society of Clinical Oncology 2020 Annual Meeting, Flatiron Health, Foundation Medicine, and Genentech presented plans for the Prospective Clinico-Genomic study (PCG), a low-interventional pilot that will use a technology-enabled prospective data collection platform to simplify data collection for patients with lung cancer being treated through clinical trials. The idea is collect blood samples using Foundation Medicine’s liquid biopsy assay and analyze the results through Flatiron’s platform, to see if genomic changes can be detected over the course of cancer treatment. Bobby Green, MD, chief medical officer for Flatiron Health, spoke with Managed Healthcare Executive®.

June 22, 2020

The two PCSK9 inhibitors have fallen far short of expectations. Inclisiran, which works by RNA inference, only needs to be injected twice a year. 

June 22, 2020

Pharmacy benefit managers are taking steps to be more responsible for the total cost of care and to become more transparent, while adding technology tools to support patients, payers and physicians in a post-COVID-19 world.